triiodothyronine has been researched along with ta 0910 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, H; Matsuoka, Y; Moriyasu, M; Nasu, M; Sakamoto, T; Yamamura, M | 1 |
| Arrigoni, J; Dement, WC; Kanbayashi, T; Mignot, E; Nishino, S; Shelton, J | 1 |
2 other study(ies) available for triiodothyronine and ta 0910
| Article | Year |
|---|---|
[Effect of (-)-N-[(S)-hexahydro-l-methyl-2, 6-dioxo-4-pyrimidinylcarbonyl]-L-histidyl-L-prolinamide (TA-0910), a new TRH analog, on plasma levels of TSH and thyroid hormones in rats].
Topics: Administration, Oral; Animals; Female; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1996 |
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.
Topics: Animals; Cataplexy; Disease Models, Animal; Dogs; Nootropic Agents; Protein Binding; Sleep Stages; Sleep, REM; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1997 |